CLASS II Device recall · Reported 2 Jan 2019 · FDA Enforcement Report

ST Aia-pack Acth (Acth: Adrenocorticotropic Hormone) recalled

Tosoh Bioscience is recalling ST Aia-pack Acth (Acth: Adrenocorticotropic Hormone) is designed for IN Vitro Diagnostic, distributed nationwide in the US. The recall was initiated on 30 Nov 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesall lots
Quantity recalled1085 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0676-2019
FDA event ID
81597
Recalling firm
Tosoh Bioscience, Grove City, OH
Classification
Class II
Status
Terminated
Recall initiated
30 Nov 2018
FDA classified
22 Dec 2018
Reported
2 Jan 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

30 Nov 2018Recall initiated by company
22 Dec 2018Classified by FDA+22 days
2 Jan 2019Published in enforcement report+11 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Not stated in the enforcement report.

Product as listed by the FDA

ST AIA-PACK ACTH (ACTH: Adrenocorticotropic Hormone) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of Adrenocorticotropic hormone (ACTH) in human EDT A plasma. Measurements of ACTH are used in the differential diagnosis and treatment of certain disorders of the adrenal glands such as Cushing's syndrome, adrenocortical insufficiency and the ectopic ACTH syndrome.

Where it was distributed

US Nationwide

Nationwide

Questions about this recall

Why was it recalled?

The reason has not been published.

Which lots are affected?

all lots

Where was it sold?

US Nationwide

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

5 other products · FDA event 81597

More recalls from Tosoh Bioscience

All 74

Other Test Kits & Diagnostics recalls

All 2,663